Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

NEW
STU:BT3 (USA)  
€ 0.95 +0.031 (+3.39%) Aug 25
At Loss
P/B:
4.69
Market Cap:
€ 244.93M ($ 285.74M)
Enterprise V:
€ 202.38M ($ 236.09M)
Volume:
500.00
Avg Vol (2M):
169.00
Trade In:
Volume:
500.00
At Loss
Avg Vol (2M):
169.00

Lineage Cell Therapeutics Inc Operating Data

Lineage Cell Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Lineage Cell Therapeutics Inc (STU:BT3) Operating Data Charts